SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : The New Economy and its Winners -- Ignore unavailable to you. Want to Upgrade?

To: Bill Harmond who wrote (5198)1/30/2001 2:40:03 PM
From: 16yearcycle  Read Replies (2) | Respond to of 57684
 
You know idph had 11% sequential rev growth with its main drug, by prescription, less growth than that on overall sales, and it sells at 150x year ahead e projections!? 40x forward sales and its tax rate is gonna double. This thing is completely ridiculous.

100x current earnings would be expensive and that would be $48.

No one howls much about the biotech valuatiuons but they will if the market turns on them.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News